Get Started with Nozin® Programs

Professional Healthcare

MRSA | MSSA colonization risk mitigation solutions

Personal Use

Buy Nozin®

Nozin® Nasal Sanitizer® antiseptic helps reduce the risk of infection

Increased Risk of HAIs and the Case for Patient Decolonization

WHITE PAPER

The pandemic has led to the increased adoption of innovative technology in many hospitals to help ensure the safety of patients and staff.

READ NOW

Nozin® awarded among Best Infection Prevention Products by Newsweek and The Leapfrog Group for second consecutive year.

Read more »

play

Words of a Champion

Making a difference in patient care.

Anita Mullen
RN, BSN, Infection Preventionist

play

Nozin 360 Healthcare

Better Care. Lower Costs.

play

Innovative Strategies

Reducing Infection Risk through Antiseptic-based Nasal Decolonization

Maureen Spencer
RN, M.Ed., CIC, FAPIC

Help protect your patients against infection with

Nasal Decolonization

Evidence shows nasal bacteria are a primary component in the spread of infection. Nozin® Nasal Sanitizer® antiseptic can help reduce the risk without antibiotics, improve quality of care & lower costs.

View All Testimonials

Evidence

Evidence shows that nasal bacteria are a primary component in the spread of infection.

%

30% of population carry Staph aureus in the nose⁸

%

80% of wound infections traced by DNA to bacteria in the patients’ own nose⁹

%

44% reduction in ICU infections with universal nasal and skin decolonization³

%

81% infection reduction with Nozin® added to an existing IP bundle²

Health Professionals:
Request a comprehensive analysis of your colonization risk mitigation protocols today.

© 2004-2023 Global Life Technologies Corp. All rights reserved. All trademarks are property of their respective owners. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.